Pro Medicus Management
Management criteria checks 4/4
Pro Medicus' CEO is Sam Hupert, appointed in Jan 1983, has a tenure of 41.92 years. total yearly compensation is A$965.22K, comprised of 95.5% salary and 4.5% bonuses, including company stock and options. directly owns 23.1% of the company’s shares, worth A$6.35B. The average tenure of the management team and the board of directors is 11.1 years and 8.6 years respectively.
Key information
Sam Hupert
Chief executive officer
AU$965.2k
Total compensation
CEO salary percentage | 95.5% |
CEO tenure | 41.9yrs |
CEO ownership | 23.1% |
Management average tenure | 11.1yrs |
Board average tenure | 8.6yrs |
Recent management updates
Recent updates
Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being
Nov 18With EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting Case
Nov 11Do Pro Medicus' (ASX:PME) Earnings Warrant Your Attention?
May 02Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today
Jan 15CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | AU$965k | AU$921k | AU$83m |
Mar 31 2024 | n/a | n/a | AU$76m |
Dec 31 2023 | n/a | n/a | AU$70m |
Sep 30 2023 | n/a | n/a | AU$65m |
Jun 30 2023 | AU$1m | AU$723k | AU$61m |
Mar 31 2023 | n/a | n/a | AU$56m |
Dec 31 2022 | n/a | n/a | AU$51m |
Sep 30 2022 | n/a | n/a | AU$48m |
Jun 30 2022 | AU$510k | AU$475k | AU$44m |
Mar 31 2022 | n/a | n/a | AU$41m |
Dec 31 2021 | n/a | n/a | AU$38m |
Sep 30 2021 | n/a | n/a | AU$34m |
Jun 30 2021 | AU$508k | AU$475k | AU$31m |
Mar 31 2021 | n/a | n/a | AU$28m |
Dec 31 2020 | n/a | n/a | AU$25m |
Sep 30 2020 | n/a | n/a | AU$24m |
Jun 30 2020 | AU$508k | AU$475k | AU$23m |
Mar 31 2020 | n/a | n/a | AU$23m |
Dec 31 2019 | n/a | n/a | AU$22m |
Sep 30 2019 | n/a | n/a | AU$21m |
Jun 30 2019 | AU$508k | AU$475k | AU$19m |
Mar 31 2019 | n/a | n/a | AU$17m |
Dec 31 2018 | n/a | n/a | AU$16m |
Sep 30 2018 | n/a | n/a | AU$13m |
Jun 30 2018 | AU$518k | AU$475k | AU$10m |
Compensation vs Market: Sam's total compensation ($USD601.01K) is below average for companies of similar size in the Australian market ($USD4.26M).
Compensation vs Earnings: Sam's compensation has been consistent with company performance over the past year.
CEO
Sam Hupert
41.9yrs
Tenure
AU$965,221
Compensation
Dr. Sam Aaron Hupert, M.B.B.S., MD has been the Chief Executive Officer and Managing Director at Pro Medicus Limited (alternate name: PRO Medicus Ltd.) since October 2010. Dr. Hupert serves as Member of Ad...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 41.9yrs | AU$965.22k | 23.1% A$ 6.3b | |
Co-Founder | 41.9yrs | AU$373.26k | 23.07% A$ 6.3b | |
Chief Financial Officer | 12.4yrs | AU$500.77k | 0.034% A$ 9.3m | |
GM of Europe & Global CTO | no data | AU$1.59m | 0.099% A$ 27.2m | |
GM of North America & Global Head of Marketing | no data | AU$401.25k | no data | |
People & Culture Director | 2.4yrs | no data | no data | |
Global Head of Sales - Visage Imaging Inc | 9.4yrs | AU$1.21m | 0.17% A$ 46.8m | |
Global Head of Customer Service of Visage Imaging Inc. | no data | no data | no data | |
Financial Controller & Company Secretary | 9.8yrs | no data | no data |
11.1yrs
Average Tenure
Experienced Management: PME's management team is seasoned and experienced (11.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 41.9yrs | AU$965.22k | 23.1% A$ 6.3b | |
Co-Founder | 41.9yrs | AU$373.26k | 23.07% A$ 6.3b | |
Independent Non-Executive Director | 3.3yrs | AU$125.00k | 0.0020% A$ 541.5k | |
Independent Non-Executive Director | 7.3yrs | AU$125.00k | 0.0041% A$ 1.1m | |
Chairman | 16.8yrs | AU$250.00k | 0.30% A$ 82.7m | |
Independent Non-Executive Director | 4.3yrs | AU$125.00k | 0.0018% A$ 505.7k | |
Independent Non-Executive Director | 8.6yrs | AU$125.00k | 0.0091% A$ 2.5m |
8.6yrs
Average Tenure
Experienced Board: PME's board of directors are considered experienced (8.6 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 07:50 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pro Medicus Limited is covered by 23 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Josh Kannourakis | Barrenjoey Markets Pty Limited |
John Hester | Bell Potter |
Scott Power | CGS International |